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PACHYCHOROID 
An Inherited condition? 
MATHIEU LEHMANN, MD,* ELODIE BOUSQUET, MD,*† TALAL BEYDOUN, MD,* 
FRANCINE BEHAR-COHEN, MD, PHD†‡ 
Purpose: Thick choroid (pachychoroid) is associated with central serous chorioretinop- athy 
(CSC), but whether pachychoroid is inherited is unknown. 
Methods: In a prospective observational study, ﬁrst- or second-degree relatives (16 individuals) 
of 5 patients with CSC had refraction and visual acuity measurement, fundus examination, 
nonmydriatic photography, and autoﬂuorescence photography. Eyes were graded using the 
following criteria: 0: normal fundus and autoﬂuorescence photography, 1: focal retinal pigment 
epithelium hyperﬂuorescence and/or hypoﬂuorescence and/or retinal pigment epithelial 
detachment, 2: CSC or diffuse retinal epitheliopathy. Choroid thickness was measured by 
enhanced depth imaging mode on optical coherence tomography. 
Results: Considering 395 mm as the threshold limit for normal subfoveal choroidal thickness, 
50% of the eyes from relatives had a thick choroid. Nine eyes of Grade 0 (28%) with an isolated 
pachychoroid would thus have been considered normal, if cho- roidal thickness was not included 
as a screening sign predisposing for CSC. 
Conclusion: Our observation suggests that pachychoroid could be an inherited condition with 
potentially a dominant transmission mode. Its inclusion in the phenotype of CSC for genetic 
studies should be considered. 
Choroid imaging, using optical coherence tomogra- phy enhanced depth imaging function, 
wasﬁrst described by Margolis and Spaide in 2008.1,2Multiple studies have measured choroidal 
thickness as a func- tion of age, axial length,3,4 and circadian rhythm,5 thus deﬁning the 
normality limits. Table 1 summarizes cho- roid measurements performed on normal subjects and 
reported in different studies. With the emergence of this new imaging modality, the range o 
retinal pathol- ogies associated with increased choroid thickness or “pachychoroid” is increasing. 
 
Central serous chorioretinopathy (CSC) belongs to this spectrum of diseases associated with 
enlarged choroid. In 30 patiemts with CSC, choroidal thickness was found signiﬁcantly increased 
not only in the affected eye (445.58 ± 100.25) but also in the contralateral unaffected eye (378.35 
± 117.44), and choroid was sig- niﬁcantly larger in the affected eyes.6 In another study, 36 
patients with CSC had retrofoveal choroid thickening (459.16 ± 77.50 mm) during the acute 
phase, regression after spontaneous resolution, and normalization after photodynamic therapy 
(349.50 ± 88.99 mm).7 Other studies have conﬁrmed that one possible mechanisms of 
photodynamic therapy in CSC could be related to the reduction of permeability and dilation of 
choroidal vessels.8–10 
However, not all patients with CSC have enlarged choroids, and whether this choroidal vessels 
dilation is causative of the disease or only a favoring factor remains controversial. The fact that 
only one eye could ever show serous detachment, whereas both eyes have enlarged choroid, 
favors consider choroidal thickening as a “susceptibility factor for CSC” rather than as a 
triggering event. 
Sporadic familial cases of CSC have been re-ported11–13 until Weenink et al14 reported that 
44% among 80 relatives of 27 patients with CSC had sub- clinical signs of CSC, suggesting a 
potential autosomal transmission of the disease. Several cases of CSC in two families with 
anxious proﬁles have raised the hypothesis that the inheritance could rather be related to speciﬁc 
psychological proﬁle15 rather than CSC inheritance per se. In a larger study including 30 rel- 
atives of patients with CSC, signs of CSC were found in 92% of the cases, while no familial 
history was reported, suggesting that nonsymptomatic forms of the disease could mask 
inheritance character.16 To date, no clear transmission pattern and no speciﬁc genotype have 
been associated with CSC. One of the difﬁculties of such genetic studies resides in the iden- 
tiﬁcation of a well-deﬁned phenotype. Indeed, with advanced imaging systems, a larger spectrum 
of clinical entities are being recognized from isolated choroidal enlargement (pachychoroid), 
pachychoroid pigment epitheliopathy recently described by Warrow et al,17 acute CSC, diffuse 
retinal epitheliopathy, andage-related macular degeneration–like CSC associated to choroidal 
neovascularization or pseudo polypoidal vasculopathy, having all in common a thick choroid. 
Whether a common physiopathogenic mechanism drives all these clinical manifestations remains 
to be clariﬁed. Because choroidal thickness is now recognized as a “sign” in the diagnosis of 
CSC, we have questioned whether choroidal thickness could be a sus- ceptibility inherited factor 
for CSC. 
INHERITANCE OF THICK CHOROID LEHMANN ET 
AL 
 Table 1. Choroid Measurements Performed on Normal Subjects in the Literature 
Eyes SFCT (mm) 
Hirata et al, IOVS 2011 31 191 
Shao et al, IOVS 2013 3233 254 
Branchini et al, Ophthalmology 2013 42 256 
Chhablani et al, IOVS 2012 64 264 
Kim et al, Eye 2011 30 266 
Manjunath et al, AJO 2010 34 272 
Yamashita et al, IOVS 2012 39 272 
Margolis and Spaide, AJO 2008 54 287 
Yang et al, Acta Opth 2013 15 289 
Ikuno et al, IOVS 2011 24 292 
Ouyang et al, IOVS 2011 55 297 
Spaide et al, AJO 2008 34 335 
Tan et al, IOVS 2012 24 340 
Qiang Li et al, IOVS 2011 93 342 
Branchini et al, Ophthalmology 2012 28 347 
Ikuno et al, IOVS 2010 79 354 
      
Patients and Methods 
This is a prospective observational noncomparative study. Patients were included after 
informed consent. Five patients with CSC were prospectively included at Hôtel-Dieu of Paris 
hospital from September 2012 to April 2013. All 5 patients had at least 1 eye with serous 
detachment for .3 months and retinal pigment 
                
    Sex: M/F Age Clinical Grade: OD/OS Use of Steroids Allergy Stress/Emotional Shock 
              
Family 1             
Father M 67 2/2 No Yes Burnout, 1976 
Index M 43 2/2 Inhaled No Burnout, 2008 
  Son M 15 0/0 No No No 
  Sister F 38 0/1 Oral, 2012 No Depression, 2010 
  Nephew M 14 0/0 Intravenous Yes No 
Family 2             
Index M 62 0/2 Intraarticular, 2011 No No 
  Brother M 61 0 No No No 
  Brother M 57 0 Intraarticular, 2004 No No 
  Brother M 56 1/1 No No No 
Family 3             
Index F 56 2/2 Intraarticular Yes Stress at work 
  Sister F 57 0 No No Stress at work 
  Daughter F 31 0 No No Stress at work 
  Son M 28 0 No No Stress at work 
Family 4             
Index M 64 2/2 Inhaled until 2010 No Depression, 2008 
  Sister F 60 0/1 Intraarticular, 1994 No Stress at work 
  Sister F 66 0/0 Intraarticular, 2003 Yes Stress at work 
  Daughter F 24 0/0 Inhaled Yes No 
  Son M 18 0/0 No No No 
Family 5             
Index M 59 0/2 No No No 
  Brother M 61 1/0 No No No 
  Brother M 51 1/1 Inhaled No No 
                
Index, index case in the family. 
Clinical grade, 0 normal fundus and autoﬂuorescence; 1, focal retinal pigment epithelium 
hyperﬂuorescence and/or hypoﬂuorescence and/or retinal pigment epithelial detachment in favor 
of previous asymptomatic CSR; 2, clinically obvious CSR or diffuse retinal epitheliopathy. 
epithelium alterations in at least 1 eye. Exclusion crite- ria were: myopia or hyperopia . 3 diopter 
(D), ambly- opia, any form of choroidal neovascularization, diabetes mellitus, and hypertension. 
All their ﬁrst- or second- degree relatives (36 individuals) were invited to the clinic for a free 
ophthalmologic examination. We could examine 16 relatives of the 5 patients. All individuals had 
refraction and visual acuity measurement, slit-lampand fundus examination, nonmydriatic 
photography, and a 55° autoﬂuorescence photography (Spectralis; Heidel- berg Engineering, 
Heidelberg, Germany). We assessed choroid thickness by enhanced depth imaging images 
performed with 6 linear horizontal scan of 100 averaged images: centered on the fovea, 
horizontal at 750 mm superior and inferior to the fovea, vertical at 750 mm temporal and nasal 
from the fovea. Manual measure- ment of choroid thickness was performed by two 
ophthalmologists (M.L. and E.B.) using caliper place- ment between the hyperreﬂective band 
corresponding to the retinal pigment epithelium Bruch layer and the outer hyperreﬂective band at 
thesclera–choroid interface. Measures were performed at the fovea, and every 500 mm up to 
1,500 mm nasal and temporal from the fovea. Patients were then classiﬁed from Grade 0 to 2, 
using the following criteria: 0: normal fundus and 
autoﬂuorescence photography; 1: focal retinal pigment epithelium hyperﬂuorescence and/or 
hypoﬂuorescence and/or retinal pigment epithelial detachment (in favor of previous 
asymptomatic CSC); 2: clinically obvious CSC or diffuse retinal epitheliopathy. Figure 1 shows 
example of this classiﬁcation. 
Results 
Subject Characteristics 
Twenty-one subjects (5 patients with CSC and 16 relatives), 14 men and 7 women, were 
included. Mean age was 47 years (14–67 years), 10 of 21 subjects (47.6%) had history of 
emotional stress or depression, and 11 of 21 (52.3%) had taken corticosteroids by any route in 
their medical history. History of allergy was recorded in 5 of 21 (24%) of the subjects (Table 2). 
Mean spherical equivalent (SE) of both eyes of index cases was 0.47 ± 0.49 D. The mean SE in 
eyes of relatives was−0.46 ± 1.93 D. The mean SE in Grade 0 eyes was −0.70 ± 1.79, and it was 
0.01 ± 2.1 in Grade 2 or 3 eyes. Subfoveal choroidal thickness (SFCT) was signiﬁcantly 
correlated with SE in the studied  
Fundus, Autoﬂuorescence Photography, and 
Optical Coherence Tomography Findings 
Among the 5 index cases, 3 had a bilateral disease (of Grade 2) (Figure 2). Six of the relatives 
had at least 1 eye 
showing a grade .0 (37.5%), and 9 of 32 eyes (28%) of the relatives were graded 1 or 2. The 
mean SFCT (42 eyes) was 396.64 ± 113.3 mm, with a median of 404 mm (range, 179–800 mm). 
There was a signiﬁcant difference 
 
Table 3. Subfoveolar Choroidal Thickness, Nasal (N), Temporal (T), and Fundus 
Autoﬂuorescence With 55° SD-OCT 
    SD-OCT Combined With EDI         
    OD       OS     Autoﬂuorescence 
                      
  N SFCT T   N SFCT T   OD OS 
                      
Family 1                     
Father 166 295 249 259 337 255   DRE DRE 
Index 616 800 648 550 591 615   DRE DRE 
Son 155 264 284 124 325 300   N N 
Sister 339 372 394 471 481 504   N RPE anomaly + PED 
Nephew 331 393 305 384 418 382   N N 
Family 2                     
Index 181 278 248 336 449 346   N DRE 
Brother 171 265 160 191 325 274   N N 
Brother 264 — 289 310 410 367   Macular toxoplasmosis scar N 
Brother 382 428 346 320 398 269   RPE anomaly + PED RPE anomaly + PED 
Family 3                     
Index 347 403 516 532 599 470   RPE anomaly + PED DRE 
Sister 315 429 418 431 466 408   N N 
Daughter 215 405 306 253 289 311   N N 
Son 490 340 382 542 490 398   N N 
Family 4                     
Index 315 284 282 274 444 523   DRE RPE anomaly + PEDs 
Sister 232 315 387 217 310 326   N PED 
Sister 105 193 222 151 179 188   Temporal toxoplasmosis scar N 
Daughter 387 470 496 382 490 476   N N 
Son 150 341 341 145 346 398   N N 
Family 5                     
Index 383 352 429 490 444 476   N DRE 
Brother 424 448 439 346 496 346   RPE anomaly + PED Past inferior BRVO 
Brother 419 485 451   — 423 —   PED RPE anomaly + PED 
                      
Index, index case in the family. 
BRVO, branch retinal vein occlusion; DRE, diffuse retinal epitheliopathy; N, normal; OD, right 
eye; OS, left eye; PED, pigment epithelium detachment; RPE, retinal pigment epithelium. 
in SFCT in Grade 1 or 2 eyes (448.1 ± 126.7 mm) as compared with Grade 0 eyes (3,616 ± 
89.8 mm [P = 0.038]). Mean SFCT was not statistically different in the fellow eyes and in the 
affected eyes (362.6 ± 82.79 mm and 426.4 ± 66.74 mm in the affected eye [P = 0.41]). It was 
also not statistically different between fellow eyes and healthy eyes (362.6 ± 82.7 mm vs. 361.35 
± 93.5mm [P . 0.99]). Subfoveal choroidal thickness $395 mm was found in 76.4% of affected 
eyes (Grade 1 or 2, and SFCT was ,395 mm in 60% of Grade 0 eyes). 
As shown in Table 3, mean choroidal thickness nasal to the fovea was 319.39 ± 131.85 mm as 
com- pared with 371.31 ± 108.82 mm temporal to the fovea (P = 0.067), and the mean SFCT was 
statistically high- er than that the nasal choroidal thickness (319.39 vs. 396.64, P = 0.0065). 
Subfoveal Choroidal Thickness as a Potential Inherited Sign, Predisposing to Central Serous 
Chorioretinopathy 
If we consider the SFCT as a screening sign for CSC, we obtain an ROC curve (Figure 3) with 
the best 
threshold measure at 395 mm, giving a sensitivity of 76.47% and a speciﬁcity of 60%. Area 
under the curve is 0.6894 ± 0.0835 with a conﬁdence interval at 95% from 0.5257 to 0.8532. The 
mean SFCT of the rela- tives was 375.46 ± 87 mm (vs. 464.4 ± 160.3mm in the patients) with a 
median of 395.5 mm. When con- sidering 395 mm as the threshold limit for“normal” SFCT, 50% 
of the eyes from relatives have an increased SFCT, and among those, 9 eyes (28%) were graded 
0. These eyes would have been considered “normal” if choroidal thickness was not included as a 
screening sign predisposing for CSC. 
Figure 2 represents the different family members with their grading and shows the eyes with 
SFCT.395 mm. Figure 4 shows the 4 brothers of the same family, their fundus autoﬂuorescence, 
and their spectral domain opti- cal coherence tomography. 
Discussion 
To date, no clear inheritance has been identiﬁed for CSC, even if description of family cases 
has been recognized. Inherited signs of the disease have not been yet well established, and 
whether pachychoroid should be considered as an inherited sign of the disease has not yet been 
questioned. Enhanced depth imaging mode of optical coherence tomography has allowed to 
measure choroidal thickness with increased precision. Normal 
subjects have variable SFCT depending on their age, axial length, and the time of the day. 
Subfoveal choroidal thickness was measured between 191.5 ± 74.218 and 354 ± 111 mm19 in 
normal subjects and between 345 ± 127 mm20 and 505 ± 124 mm2patients with CSC, depending 
on the studies. 
In our limited group of subjects, the mean SFCT was 448.1 ± 126.7 mm in eyes with signs of 
CSC and it was 361.6 ± 89.8 mm in Grade 0 eyes (P = 0.038), which is higher than the SFCT 
measured in emetropic eyes, suggesting that relatives of patients with CSC may have enlarged 
choroids. Indeed, the SE (−0.70 ± 1.79) in this group could not explain the larger choroidal 
thickness. 
Other studies evaluating inheritance of CSC have classiﬁed eyes depending on their 
fundus ﬁnding: normal fundus, retinal pigment epithelium atrophy and/or pig- ment epithelial 
detachment, or chronic CSC.14 Eyes pre- senting classic signs of CSC or suspected CSC are thus 
considered as affected. Taken the same classiﬁcation criteria, we designed an ROC curve with 
affected and healthy patients, considering their SFCT as a screening test. The best sensibility was 
76.47%, for a speciﬁcity of sample (r = 0.53, P = 0.01, Pearson’s correlation). 
 
 
Fig. 1. Example of clinical grad- ing. A and B. Grade 0 deﬁned as normal fundus and auto-ﬂuorescence (A). In that 
case, the eye had an increased SFCT (B). Cand D. Grade 1 is deﬁned as focal retinal pigment epithelium hyper- 
autoﬂuorescence (C) and/or hy- poautoﬂuorescence and/or retinal pigment epithelial detachment (D). In this case, it 
is associated with increased SFCT (D). E and F.Grade 2 is deﬁned as clinically obvious CSC or diffuse retinal 
epitheliopathy. Hypoauto-ﬂuorescence and hyper- autoﬂuorescence (F) associated with irregular retinal pigment epi- 
thelium, SFR, and elongated outer segments, witnessing chronic CSC. 
 
 
Fig. 2. Family trees of the 5 families: 0: normal fundus autoﬂuorescence; 1: focal retinal pigment epithelium 
hyperﬂuorescence and/or hypoﬂuor- escence and/or retinal pigment epithelial detachment in favor of previous 
asymptomatic CSC; 2: clinically obvious CSC or diffuse retinal epitheli- opathy. Gray color indicates 
SFCT .395 mm. 
 
 
 
 Fig. 3. ROC curve of SFCT as a screening tool for CSC. Se, sensibility; Sp, speciﬁcity. 
 
Fig. 4. Spectral domain optical coherence tomography and autoﬂuorescence images of members of family N° 2 
patient index. The fellow eye has a normal fundus autoﬂuorescence (B) and a normal SFCT (A). The pathologic eye 
shows a chronic CSC (C) and a SFCT of 449mm (D). One of his brothers with enlarged choroids (428 and 398 mm 
[E and H]) shows fundus autoﬂuorescence alterations in the interpapillomacular area on both eyes (white 
arrow, F and G). Another brother with a normal nasal and temporal choroidal thickness (I) and a toxoplasmosis scar 
on the right eye fundus associated with subfoveal thinning. The choroidal thickness at the border of the scar is 
299 mm (J). His left eye shows normal fundus autoﬂuorescence (K) and a thickened subfoveolar choroid (410 mm 
[L]). The last brother has a strictly normal fundus autoﬂuorescence in both eyes (N and O) and a normal SFCT 
(M and P 
